Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
NCT ID: NCT04591145
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1400 participants
OBSERVATIONAL
2020-10-09
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-center and Multi-modal Deep Learning Study of Gastric Cancer
NCT05001321
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
NCT05523245
Post Radiotherapy MRI Based AI System to Predict Radiation Proctitis for Pelvic Cancers
NCT04918992
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT06035250
Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer
NCT04278274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational group
Patients received bowel preparation and colonoscopy. The withdrawal phase video was saved and their lesions detection was record.
Observational group
Patient receive the standard bowel preparation strategy and routine colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational group
Patient receive the standard bowel preparation strategy and routine colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read, understand and sign informed consent forms;
* The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.
Exclusion Criteria
* Patients with galactosemia;
* Pregnant or lactating women;
* Patients used lactulose, a stimulant, or laxative within 7 days;
* Patients refused to sign informed consent forms.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hubei Hospital of Traditional Chinese Medicine
OTHER
Wuhan Central Hospital
OTHER
Wuhan Third Hospital
OTHER
The General Hospital of Central Theater Command
OTHER
The Third People's Hospital of Hubei Province
OTHER
Wuhan Puren Hospital
OTHER
Wuhan Puai Hospital
UNKNOWN
Tian You Hospital Affiliated to Wuhan University of Science and Technology
UNKNOWN
Wuhan Red Cross Hospital
UNKNOWN
Renmin Hospital of Wuhan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA-20-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.